[go: up one dir, main page]

DK388789D0 - Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna - Google Patents

Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna

Info

Publication number
DK388789D0
DK388789D0 DK388789A DK388789A DK388789D0 DK 388789 D0 DK388789 D0 DK 388789D0 DK 388789 A DK388789 A DK 388789A DK 388789 A DK388789 A DK 388789A DK 388789 D0 DK388789 D0 DK 388789D0
Authority
DK
Denmark
Prior art keywords
humant
dna
coding
protein
production
Prior art date
Application number
DK388789A
Other languages
English (en)
Other versions
DK388789A (da
Inventor
Tamotsu Hashimoto
Mikiko Takahashi
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of DK388789D0 publication Critical patent/DK388789D0/da
Publication of DK388789A publication Critical patent/DK388789A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK388789A 1988-08-09 1989-08-08 Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna DK388789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63197144A JPH0246296A (ja) 1988-08-09 1988-08-09 雑種プロテインｃ及びその製造方法

Publications (2)

Publication Number Publication Date
DK388789D0 true DK388789D0 (da) 1989-08-08
DK388789A DK388789A (da) 1990-02-10

Family

ID=16369490

Family Applications (1)

Application Number Title Priority Date Filing Date
DK388789A DK388789A (da) 1988-08-09 1989-08-08 Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna

Country Status (9)

Country Link
EP (1) EP0354504A2 (da)
JP (1) JPH0246296A (da)
KR (1) KR900002795A (da)
AU (1) AU3937289A (da)
DK (1) DK388789A (da)
FI (1) FI893724A7 (da)
IL (1) IL91234A0 (da)
NO (1) NO893196L (da)
PT (1) PT91391A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
AU7168591A (en) * 1989-12-29 1991-07-24 Zymogenetics Inc. Hybrid protein c
JPH04127174U (ja) * 1991-05-09 1992-11-19 株式会社シマノ 釣り用リール
US5618714A (en) * 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
CA2271232C (en) * 1996-11-08 2005-02-22 Oklahoma Medical Research Foundation Modified protein c and methods of use thereof
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6017882A (en) * 1997-10-23 2000-01-25 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6998122B1 (en) 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
WO2001057193A2 (en) 2000-02-02 2001-08-09 Eli Lilly And Company Protein c derivatives
JP2003521938A (ja) 2000-02-11 2003-07-22 イーライ・リリー・アンド・カンパニー プロテインｃ誘導体
EP1982732A3 (en) 2000-02-11 2011-06-08 Bayer HealthCare LLC Factor VII or VIIA-like conjugates
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
EP1370649A1 (en) * 2001-03-02 2003-12-17 T.A.C. Thrombosis and Coagulation AB Protein c variants
NZ536340A (en) 2002-04-30 2006-09-29 Maxygen Holdings Ltd Factor VII or VIIa polypeptide variants with N-glycosylation
ES2327044T3 (es) 2003-03-20 2009-10-23 Bayer Healthcare Llc Variantes de fvii o fviia.
WO2004111242A1 (en) 2003-06-19 2004-12-23 Maxygen Holdings Ltd. FACTOR VII OR VIIa GLA DOMAIN VARIANTS

Also Published As

Publication number Publication date
NO893196D0 (no) 1989-08-08
FI893724L (fi) 1990-02-10
JPH0246296A (ja) 1990-02-15
IL91234A0 (en) 1990-03-19
FI893724A7 (fi) 1990-02-10
NO893196L (no) 1990-02-12
PT91391A (pt) 1990-03-08
AU3937289A (en) 1990-04-12
DK388789A (da) 1990-02-10
FI893724A0 (fi) 1989-08-07
KR900002795A (ko) 1990-03-23
EP0354504A2 (en) 1990-02-14

Similar Documents

Publication Publication Date Title
DK388789A (da) Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
FI912619A0 (fi) Hyaluronsyraestrar, foerfarande foer framstaellning daerav samt sanitets- och kirurgiska produkter innehaollande hyaluronsyraestrar.
DK385686A (da) Hybridplasminogenaktivator, vektorer og dna-enheder, som koder derfor samt aktivatorens anvendelse
DK317288D0 (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DK110885D0 (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
FI893644A7 (fi) Tetrahydro-1-bents-/c,d/-indolipropionihapposulfoniamideja
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK4387D0 (da) Human-praepo-insulinlignende-vaerkstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne
IT1214533B (it) 2-osso-1 solfonil sostituito amminocarbonil azetidine e procedimento per ottenerle.
DK38989A (da) Dna-sekvens
NO174970C (no) Rekombinant DNA, rekombinant DNA-vektor samt vertscelle
NO860550L (no) Polypeptider av rhinovirus, samt dna-molekyler som koder for slike.
FI861653A7 (fi) Eristetty DNA-yhdiste, joka koodaa rekombinantti DNA isopenisilliini N-syntetaasia, sitä sisältävät vektorit ja menetelmä isopenisilliini N-syntetaasiaktiivisuuden tuottamiseksi näiden avulla
DK300787A (da) Dna-struktur fra cytomegalivirus, ekspressionsvektor derfor samt dermed kodede proteinstrukturer og disses anvendelse
DE69013458D1 (de) Plasmide und Wirtszellen zur Expression von INA Protein (Ice nucleating protein).
DK188286D0 (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
DK165951C (da) Imidazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse
DK384088A (da) Substituerede benzimidazoler, deres fremstilling, praeparater indeholdende disse samt deres anvendelse som laegemidler
FI860746A0 (fi) Nya kefalosporiner, foerfarande foer deras framstaellning samt anvaendning i laekemedel.
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
FI862382A0 (fi) Nya fenantrenderivat, foerfarande foer framstaellning daerav samt fungicida kompositioner innehaollande dessa.
DK319888A (da) Dna-fragmenter
FI865335A0 (fi) Regleringsanordning foer kontaminationer i en foerbraenningsmotor.
FI864716L (fi) Nya kefalosporiner, deras framstaellningsfoerfarande samt deras anvaendning som laekemedel.
NO864742D0 (no) Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.

Legal Events

Date Code Title Description
ATS Application withdrawn